Sheba Medical Center Study Reveals Pfizer/BioNTech Produces more Antibodies Targeting COVID-19

Sheba Medical Center Study Reveals PfizerBioNTech Produces more Antibodies Targeting COVID-19

Recently, Sheba Medical Center based in Ramat Gan, Israel, shared some promising observations associated with the Pfizer/BioNTech COVID-19 vaccine. To date, over 7,000 employees have received the vaccination and recently Shema Medical Center researchers analyzed the levels of antibodies associated with those who received the vaccine. They found after assessing blood tests of 102 vaccinated employees that the levels of antibodies against COVID-19 are higher in those who have received both doses of the vaccination versus those that had already had the disease and recovered.

Dr. Gili Regev-Yochay, director of Sheba Medical Center Infectious Disease Epidemiology Unit reports that the results of this internal study “are in line with Pfizer’s experiment and even better than expected,” as reported in Sheba Medical Center news.

98% of the 102 patients tested evidenced a six-to 12-fold increase in the antibodies against SARS-CoV-2.  In a couple of fringe cases, the patents were not able to develop antibodies, for whatever reason. The investigators at Sheba are probing these cases now.

How long do the Pfizer/BioNTech vaccine-induced antibodies last?

This is unknown. That is, the...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee